Champions Oncology (CSBR)
(Delayed Data from NSDQ)
$5.03 USD
-0.04 (-0.79%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $5.04 +0.01 (0.20%) 7:10 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/20/2024
Time: -- |
1/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Champions Oncology (CSBR) reported earnings of -$0.15 per share, beating the Zacks Consensus Estimate of $-0.17 per share. This reflects a positive earnings surprise of 11.76%. Look out for CSBR's next earnings release expected on March 20, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year increase of 77.78%.
Earnings History
Price & Consensus
Zacks News for CSBR
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings and Revenue Estimates
CSBR: What are Zacks experts saying now?
Zacks Private Portfolio Services